168 related articles for article (PubMed ID: 18508633)
1. Cytogenetic biomarkers for human cancer.
Keen-Kim D; Nooraie F; Rao PN
Front Biosci; 2008 May; 13():5928-49. PubMed ID: 18508633
[TBL] [Abstract][Full Text] [Related]
2. Molecular cytogenetic aspects of hematological malignancies: clinical implications.
Chen Z; Sandberg AA
Am J Med Genet; 2002 Oct; 115(3):130-41. PubMed ID: 12407693
[TBL] [Abstract][Full Text] [Related]
3. Single-nucleotide polymorphism array (SNP-A) improves the identification of chromosomal abnormalities by metaphase cytogenetics in myelodysplastic syndrome.
da Silva FB; Machado-Neto JA; Bertini VHLL; Velloso EDRP; Ratis CA; Calado RT; Simões BP; Rego EM; Traina F
J Clin Pathol; 2017 May; 70(5):435-442. PubMed ID: 27836923
[TBL] [Abstract][Full Text] [Related]
4. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
[TBL] [Abstract][Full Text] [Related]
5. Chromosomal abnormalities in myelodysplastic syndromes and acute myeloid leukemia.
Machnicki JL; Bloomfield CD
Clin Lab Med; 1990 Dec; 10(4):755-67. PubMed ID: 2272173
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetics in the genomic era.
Granada I; Palomo L; Ruiz-Xivillé N; Mallo M; Solé F
Best Pract Res Clin Haematol; 2020 Sep; 33(3):101196. PubMed ID: 33038985
[TBL] [Abstract][Full Text] [Related]
7. [Cytogenetics of myelodysplastic syndromes and its impact as prognostic factor].
Borjas-Gutiérrez C; Domínguez-Cruz MD; González-García JR
Rev Med Inst Mex Seguro Soc; 2017; 55(4):481-489. PubMed ID: 28591503
[TBL] [Abstract][Full Text] [Related]
8. [Cytogenetics in the study of malignant blood diseases].
García JL; Hernández JM; Gutiérrez NC; Fernández P; Ríos A
Sangre (Barc); 1996 Aug; 41(4):289-95. PubMed ID: 8984670
[No Abstract] [Full Text] [Related]
9. Retrospective evaluation of the clinical and laboratory data from 300 patients of various hematological malignancies with chromosome 3 abnormalities.
Liu D; Zhang Y; Chen S; Pan J; He X; Liang J; Chen Z
Cancer Genet; 2015 Jun; 208(6):333-40. PubMed ID: 26032184
[TBL] [Abstract][Full Text] [Related]
10. Regional cancer cytogenetics: a report on 1,143 diagnostic cases.
Perkins D; Brennan S; Carstairs K; Bailey D; Pantalony D; Poon A; Fernandes B; Dubé I
Cancer Genet Cytogenet; 1997 Jul; 96(1):64-80. PubMed ID: 9209473
[TBL] [Abstract][Full Text] [Related]
11. Relapse and cytogenetic evolution in myeloid neoplasms.
Ertz-Archambault N; Kelemen K
Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of del(20q) in patients with hematological malignancies.
Brezinová J; Zemanová Z; Ransdorfová S; Sindelárová L; Sisková M; Neuwirtová R; Cermák J; Michalová K
Cancer Genet Cytogenet; 2005 Jul; 160(2):188-92. PubMed ID: 15993278
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic polyclonality in hematologic malignancies.
Johansson B; Billström R; Broberg K; Fioretos T; Nilsson PG; Ahlgren T; Malm C; Samuelsson BO; Mitelman F
Genes Chromosomes Cancer; 1999 Mar; 24(3):222-9. PubMed ID: 10451702
[TBL] [Abstract][Full Text] [Related]
14. Is there an association with constitutional structural chromosomal abnormalities and hematologic neoplastic process? A short review.
Panani AD
Ann Hematol; 2009 Apr; 88(4):293-9. PubMed ID: 19129995
[TBL] [Abstract][Full Text] [Related]
15. 7q22 deletion in myeloid malignancies: be attentive to the design of the FISH probe.
Struski S; Luquet I
Ann Biol Clin (Paris); 2019 Apr; 77(2):229-230. PubMed ID: 30907375
[No Abstract] [Full Text] [Related]
16. Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes.
Solé F; Luño E; Sanzo C; Espinet B; Sanz GF; Cervera J; Calasanz MJ; Cigudosa JC; Millà F; Ribera JM; Bureo E; Marquez ML; Arranz E; Florensa L
Haematologica; 2005 Sep; 90(9):1168-78. PubMed ID: 16154839
[TBL] [Abstract][Full Text] [Related]
17. [From conventional cytogenetics to microarrays. Fifty years of Philadelphia chromosome].
Hernández JM; Granada I; Solé F;
Med Clin (Barc); 2011 Jul; 137(5):221-9. PubMed ID: 20591449
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetics in solid tumors: lessons from the Philadelphia Chromosome.
Sudoyo AW; Hardi F
Acta Med Indones; 2011 Jan; 43(1):68-73. PubMed ID: 21339549
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of chromosome number deviations in myelodysplastic syndromes and in acute non-lymphoid leukemia].
Balogh E; Oláh E; Nagy A; Kovács I; Kiss A
Orv Hetil; 1989 Mar; 130(13):655-63. PubMed ID: 2657551
[TBL] [Abstract][Full Text] [Related]
20. Genetic Testing in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
Nardi V; Hasserjian RP
Surg Pathol Clin; 2016 Mar; 9(1):143-63. PubMed ID: 26940274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
